HSDT Solana Company
HealthcareAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
0.89
P/S
13.94
EV/EBITDA
-3.39
DCF Value
$-11.54
FCF Yield
-13.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
94.2%
Operating Margin
-196.6%
Net Margin
-1427.1%
ROE
-155.3%
ROA
-68.2%
ROIC
-9.5%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $3.6M | $-99.8M | $— |
| Q4 null | $5.2M | $325.6M | $— |
| FY null | $6.0M | $-40.9M | $— |
| Q3 null | $697.0K | $-352.8M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
1.07
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.